Recombinant multi-species PPP5C protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PPP5C protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a serine/threonine phosphatase which is a member of the protein phosphatase catalytic subunit family. Proteins in this family participate in pathways regulated by reversible phosphorylation at serine and threonine residues; many of these pathways are involved in the regulation of cell growth and differentiation. The product of this gene has been shown to participate in signaling pathways in response to hormones or cellular stress, and elevated levels of this protein may be associated with breast cancer development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2011]
The Alternative Names of target: PP5,PPP5,PPP5C,PPP5D1,PPT,PPT),Ppp5c,Protein phosphatase T (PP-T,Serine/threonine-protein phosphatase 5
Go
to PPP5C products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T04123-Ag-1/ GM-Tg-hg-T04123-Ag-2 | Human PPP5C protein | Human |
| GM-Tg-rg-T04123-Ag-1/ GM-Tg-rg-T04123-Ag-2 | Rat PPP5C protein | Rat |
| GM-Tg-mg-T04123-Ag-1/ GM-Tg-mg-T04123-Ag-2 | Mouse PPP5C protein | Mouse |
| GM-Tg-cynog-T04123-Ag-1/ GM-Tg-cynog-T04123-Ag-2 | Cynomolgus/Rhesus macaque PPP5C protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T04123-Ag-1/ GM-Tg-felg-T04123-Ag-2 | Feline PPP5C protein | Feline |
| GM-Tg-cang-T04123-Ag-1/ GM-Tg-cang-T04123-Ag-2 | Canine PPP5C protein | Canine |
| GM-Tg-bovg-T04123-Ag-1/ GM-Tg-bovg-T04123-Ag-2 | Bovine PPP5C protein | Bovine |
| GM-Tg-equg-T04123-Ag-1/ GM-Tg-equg-T04123-Ag-2 | Equine PPP5C protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T04123-Ag-1/ GM-Tg-hg-T04123-Ag-2;
GM-Tg-rg-T04123-Ag-1/ GM-Tg-rg-T04123-Ag-2;
GM-Tg-mg-T04123-Ag-1/ GM-Tg-mg-T04123-Ag-2; GM-Tg-cynog-T04123-Ag-1/ GM-Tg-cynog-T04123-Ag-2; GM-Tg-felg-T04123-Ag-1/ GM-Tg-felg-T04123-Ag-2; GM-Tg-cang-T04123-Ag-1/ GM-Tg-cang-T04123-Ag-2; GM-Tg-bovg-T04123-Ag-1/ GM-Tg-bovg-T04123-Ag-2; GM-Tg-equg-T04123-Ag-1/ GM-Tg-equg-T04123-Ag-2 |
| Products Name | PPP5C protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | PPP5C |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PPP5C protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.